Diabetes 69(11):22292237 American Diabetes Association Professional Practice Committee (2024) 11
Opioids illustrate this dynamic
The Risks of DIY Dose Splitting Taking matters into your own hands when it comes to prescription dosages carries significant health risks
Semaglutide is not a medication you can start at full dose
According to the World Health Organization, over one billion people will be obese by 2022, with 650 million adults, 340 million adolescents, and 39 million children being the most obese

For WorldatWork Members Considerations to Manage the Costs of GLP-1 Coverage, Workspan Daily Plus+ article Total Rewards Inventory of Programs & Practices, research Total Rewards Inventory Checklist, tool Five Emerging Workplace Trends Affecting the Employee Experience, Journal of Total Rewards article For Everyone As Interest in GLP-1 Drugs Spikes, Employers Weigh the Costs, Benefits, Workspan Daily article Employers Grapple with the Rising Costs and Popularity of Specialty Weight-Loss Drugs, Workspan Daily article Most Employers Hold Firm on Well-Being Offerings But Want Results, Workspan Daily article As Health Costs Spike, Total Rewards and CFO Collaboration Is Crucial, Workspan Daily article Employers Facing Healthcare Cost Containment Challenge for 2025, Workspan Daily article Glucagon-like peptide-1 (GLP-1) medications are more top-of-mind than ever this year for employees and theyre looking to their employers to help pay for them